GlassScriptPhysician profile
Andrea Toro
NPI 1033853031
$8,825.32
in general payments reported to CMS, 2019-2025
54 companies · $3,390 in 2025
The $3,390 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $809 · 2023: $2,089 · 2024: $2,536 · 2025: $3,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,450 · Education: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,450.27 |
| Education | $565.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $787.96 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $645.04 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Incyte Corporation | $609.39 | 2022-2025 | Jakafi, Monjuvi, Zynyz |
| Janssen Biotech, INC. | $526.97 | 2023-2025 | Talvey, Darzalex, Rybrevant |
| Astrazeneca Pharmaceuticals LP | $463.16 | 2023-2025 | Enhertu, Calquence, Lynparza |
| Novartis Pharmaceuticals Corporation | $455.95 | 2022-2025 | |
| Gilead Sciences, INC. | $433.49 | 2023-2025 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $335.41 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $333.39 | 2022-2025 | Alunbrig, Fruzaqla, Iclusig |
| Lilly USA, LLC | $331.04 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Sobi, INC | $326.97 | 2023-2025 | |
| Genzyme Corporation | $321.06 | 2022-2025 | |
| Seagen INC. | $319.70 | 2022-2024 | Adcetris, Padcev, Tivdak |
| Abbvie INC. | $264.37 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $198.88 | 2023-2025 | Libtayo |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $192.61 | 2023-2025 | |
| Daiichi Sankyo INC. | $168.72 | 2023-2024 | Enhertu |
| Eisai INC. | $160.45 | 2022-2025 | |
| Puma Biotechnology, INC. | $156.13 | 2022-2025 | |
| Aveo Pharmaceuticals, INC. | $142.34 | 2022-2025 | Fotivda |
| Array Biopharma INC | $120.57 | 2023-2025 | Braftovi, Mektovi, Tukysa |
| Glaxosmithkline, LLC. | $106.62 | 2023-2025 | Ojjaara |
| Tempus Ai, INC | $106.00 | 2025 | Xt Cdx |
| Amgen INC. | $100.32 | 2022-2023 | Kyprolis, Blincyto |
| Pharmacosmos Therapeutics INC. | $82.04 | 2023-2025 | Monoferric |
| Dendreon Pharmaceuticals LLC | $78.75 | 2025 | Provenge |
| Mirati Therapeutics, INC. | $78.05 | 2023 | Krazati |
| Alexion Pharmaceuticals, INC. | $71.92 | 2024-2025 | Ultomiris |
| Stemline Therapeutics INC. | $68.30 | 2024-2025 | Orserdu |
| E.R. Squibb & Sons, L.L.C. | $65.07 | 2024 | Krazati, Augtyro |
| Taiho Oncology, INC. | $64.09 | 2023-2025 | |
| Kite Pharma, INC. | $56.48 | 2024-2025 | Yescarta |
| Astellas Pharma US INC | $51.33 | 2023-2024 | Xtandi, Xospata |
| Kyowa Kirin, INC. | $47.13 | 2023-2024 | Poteligeo |
| Servier Pharmaceuticals LLC | $44.13 | 2022-2024 | |
| Exelixis INC. | $40.65 | 2024-2025 | Cabometyx |
| Morphosys, US INC. | $40.40 | 2022-2023 | Monjuvi |
| Alnylam Pharmaceuticals INC. | $37.02 | 2023-2024 | Givlaari |
| Adaptive Biotechnologies Corporation | $36.77 | 2022-2023 | Clonoseq |
| Blueprint Medicines Corporation | $36.63 | 2023-2025 | Ayvakit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.48 | 2024-2025 | Gilotrif |
| Karyopharm Therapeutics INC. | $34.73 | 2024-2025 | Xpovio |
| Ipsen Biopharmaceuticals, INC | $31.62 | 2023-2024 | Onivyde, Somatuline Depot |
| Pharmaessentia USA Corporation | $25.05 | 2024 | Besremi |
| Adc Therapeutics America, INC. | $24.43 | 2025 | |
| Deciphera Pharmaceuticals INC. | $22.56 | 2023 | Qinlock |
| Sirtex Medical INC | $22.05 | 2023 | Sir-Spheres Microspheres |
| Sumitomo Pharma America, INC. | $20.89 | 2025 | Orgovyx |
| Emd Serono, INC. | $20.22 | 2024 | |
| Sun Pharmaceutical Industries INC. | $19.03 | 2025 | |
| Legend Biotech USA INC. | $17.74 | 2025 | Carvykti |
| Cti Biopharma Corp. | $17.26 | 2023 | Vonjo |
| Agios Pharmaceuticals, INC. | $14.98 | 2022 | |
| Foundation Medicine, INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Toro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.